Condition
Perimenopausal Bone Loss
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07120997Not ApplicableRecruitingPrimary
Prunes Preventing Bone Loss in Perimenopause
NCT04942691Not ApplicableCompletedPrimary
Prevention of Osteoporosis: Effects of Mini-trampoline Training on the Bone Remodeling
NCT00221312CompletedPrimary
Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
NCT00290212Phase 2CompletedPrimary
Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause
Showing all 4 trials